TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Executive Medicine AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
446
|
432 | |
| Financial expenses |
1
|
1 | |
| Earnings before taxes |
5
|
41 | |
| EBITDA |
5
|
42 | |
| Total assets |
64
|
53 | |
| Current assets |
61
|
51 | |
| Current liabilities |
52
|
42 | |
| Equity capital |
12
|
12 | |
| - share capital |
5
|
4 | |
| Employees (average) |
6
|
7
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
18.8%
|
22.6% | |
| Turnover per employee |
64
|
86 | |
| Profit as a percentage of turnover |
1.1%
|
9.5% | |
| Return on assets (ROA) |
9.4%
|
79.2% | |
| Current ratio |
117.3%
|
121.4% | |
| Return on equity (ROE) |
41.7%
|
341.7% | |
| Change turnover |
13
|
160 | |
| Change turnover % |
-21%
|
3%
|
59% |
| Chg. No. of employees |
-1
|
2
|
2 |
| Chg. No. of employees % |
-14%
|
40%
|
67% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.